Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06425380
Status:
RECRUITING
Last Update Posted:
2024-05-22
First Post:
2024-05-17
Brief Title:
Pilot Open-Label Trial of Resistant Potato Starch in Patients with Cirrhosis and Overt Hepatic Encephalopathy
Sponsor:
University of Michigan
Organization:
University of Michigan
Study Overview
Official Title:
Pilot Open-Label Trial of Resistant Potato Starch in Patients with Cirrhosis and Overt Hepatic Encephalopathy
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This research is studying how a food product resistant potato starch which is a dietary supplement made from potato starch affects the gut bacteria of people with cirrhosis and hepatic encephalopathy
The researchers in this study want to understand how potato starch works in the subjects body and how the body will react to it Along with taking the study product participants health-related information and stool will be collected for this research study
The researchers in this study want to understand how potato starch works in the subjects body and how the body will react to it Along with taking the study product participants health-related information and stool will be collected for this research study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None